Taking the cell by stealth or storm? Protein Transduction Domains (PTDs) as versatile vectors for delivery

DNA and Cell Biology

Volumn 21, Issue 12, 2002, Pages 879-894

  Bogoyevitch, Marie A ^a,b   Kendrick, Tulene S ^a   Ng, Dominic C H ^a   Barr, Renae K ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CASPASE 3; FIBROBLAST GROWTH FACTOR RECEPTOR; GUANOSINE TRIPHOSPHATASE; HERMES ANTIGEN; LIPOSOME; MITOGEN ACTIVATED PROTEIN KINASE; NANOPARTICLE; OLIGOMER; PEPTIDE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STAT3 PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; CELL MEMBRANE; CELL SURFACE; CELL TYPE; CYTOPLASM; DRUG DELIVERY SYSTEM; ENZYME ACTIVATION; IN VIVO STUDY; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEINS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0036968308     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454902762053846     Document Type: Review

References (91)

1. α arrest osteoclastogenesis. J. Biol. Chem. 276, 30499-30503.
2. ADACHI, T., PAZDRAK, K., STAFFORD, S., and ALAM, R. (1999). The mapping of the lyn kinase binding site of the common b-subunit of IL3/Granulocyte-Macrophage Colony-Stimulating Factor/IL5 receptor. J. Immunol. 162, 1496-1501.
3. ALLINQUANT, B., HANTRAYE, P., MAILLEUX, P., MOYA, K., BOUILLOT, C., and PROCHIANTZ, A. (1995). Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. 128, 919-927.
4. ARAP, W., PASQUALINI R., and RUOSLAHTI, E. (1998). Cancer treatment by targeted drug delivery to tumor vascalature in a mouse model. Science 279, 323-324.
5. BECKER-HAPAK, M., MCALLISTER, S.S., and DOWDY, S.F. (2001). TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256.
6. BELLET-AMALRIC, E., BLAUDEZ, D., DESBAT, B., GRANER, F., GAUTHIER, F., and RENAULT, A. (2000). Interaction of the third helix of Antennapedia homeodomain and a phospholipid monolayer, studied by ellipsometry and PM-IRRAS at the air-water interface. Biochim. Biophys. Acta 1467, 131-143.
7. BERLOSE, J.P., CONVERT, O., DEROSSI, D., BRUNISSEN, A., and CHASSAING, G. (1996). Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur. J. Biochem. 242, 379-386.
8. BOLTON, S.J., JONES, D.N.C., DARKER, J.G., EGGLESTON, D.S., HUNTER, A.J., and WALSH, F.S. (2000). Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain. Eur. J. Neurosci. 12, 2847-2855.
9. β-cell death. Diabetes 50, 77-82.
10. CHATELIN, L., VOLVOVITCH, M., JOLIOT, A.H., PEREZ, F., and PROCHIANTZ, A. (1996). Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei. Mech. Dev. 55, 111-117.
11. CHEN, C.-M., and BEHRINGER, R.R. (2001). CREating breakthroughs. Nature Biotech. 19, 921 922.
12. CHEN, L.L., FRANKEL, A.D., HARDER, J.L., FAWELL, S., BARSOUM, J., and PEPENSKY, B. (1995). Increased cellular uptake of the human immunodeficiency virus protein after modification with biotin. Anal. Biochem. 227, 168-175.
13. KB. J. Biol. Chem. 276, 37621-37629.
14. CUSSAC, D., VIDAL, M., LEPRINCE, C., LIU, W.-Q., CORNILLE, F., TIRABOSCHI, G., ROQUES, B.P., and GARBAY, C. (1999). A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J. 13, 31-38.
15. DEROSSI, D., JOLIOT, A.H., CHASSAING, G., and PROCHIANTZ, A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450.
16. DEROSSI, D., CALVET, S., TREMBLEUU, A., BRUNISSEN, A., CHASSAING, G., and PROCHIANTZ, A. (1996). Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188-18193.
17. DEROSSI, D., WILLIAMS, E.J., GREEN, P.J., DUNICAN, D.J., and DOHERTY, P. (1998). Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem. Biophys. Res. Commun. 251, 148-152.
18. DOSTMANN, W.R.G., TAYLOR, M.S., NICKL, C.K., BRAYDEN, J.E., FRANK, R., and TEGGE, W.J. (2000). Highly-specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ia inhibit NO-induced cerebral dilation. Proc. Natl. Acad. Sci. USA 97, 14772-14777.
19. DRIN, G., MAZEL, M., CLAIR, P., MATHIEU, D., KACZOREK, M., and TEMSAMANI, J. (2001). Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur. J. Biochem. 268, 1304-1314.
20. ELLERBY, H.M., ARAP, W., ELLERBY, L.M., KAIN, R., ANDRUSIAK, R., DEL RIO, G., KRAJEWSKI, S., LOMBARDO, C.R., RAO, R., RUOSLAHTI, E., BREDESEN, D.E., and PASQUALINI R. (1999). Anti-cancer activity of targeted pro-apoptotic peptides. Nature Med. 5, 1032-1038.
21. ELLIOTT, G., and O'HARE, P. (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
22. ELMQUIST, A., LINDGREN, M., BARTFAI, T., and LANGEL, U. (2001). VE-Cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp. Cell Res. 269, 237-244.
23. FAHRAEUS, R., PARAMIO, J.M., BALL, K.L., LAIN, S., and LANE, D.P. (1996). Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr. Biol. 6, 84-91.
24. FAWELL, S., SEERY, J., DAIKH, Y., MOORE, C., CHEN, L.L., PEPINSKY, B., and BARSOUM, J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91, 664-668.
25. FENTON, M., BONE N., and SINCLAIR, A.J. (1998). The efficient and rapid import of a peptide into primary B and T lymphocytes and a lymphoblastoid cell line. J. Immmunol. Methods 212, 41-48.
26. FISCHER, P.M., ZHELEV, N.Z., WANG, S., MELVILLE, J.E., FAHREUS, R., and LANE, D.P. (2000). Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector penetratin. J. Peptide Res. 55, 163-172.
27. FRANKEL, A.D., and PABO, C.O. (1988). Cellular uptake of the tat protein from human immumodeficiency virus. Cell 55, 1189-1193.
28. FUJIMOTO, K., HOSOTANI, R., MIYAMOTO, Y., DOI, R., KOSHIBA, T., OTAKA, A., FUJII, N., BEAUCHAMP, R.D., and IMAMURA, M. (2000). Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia p-16 INK4A fusion peptide in pancreatic cancer cells. Cancer Lett. 159, 151-158.
29. FUTAKA, S., SUZUKI, T., OHASHI W., YAGAMI, T., TANAKA, S., UEDA, K., and SUGIURA, Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276, 5836-5840.
30. 1. Cancer Res. 59, 2577-2580.
31. GREEN, M., and LOEWENSTEIN, P.M. (1988). Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-1188.
32. HALL, H., WILLIAMS, E.J., MOORE, S.E., WALSH, F.S., PROCHIANTZ, A., and DOHERTY, P. (1996). Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Cart. Biol. 6, 580-587.
33. HALLBRINK, M., FLOREN, A., ELMQUIST, A., POOGA, M., BARFAI, T., and LANGEL, U. (2001). Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515, 101-109.
34. HAN, K., JEON, M.J., KIM, K.A., PARK, J., and CHOI, S.Y. (2000). Efficient delivery of GFP by homeodomains of Drosophila Fushitarazu and Engrailed proteins. Mol. Cells 10, 728-732.
35. HO, A., SCHWARZE, S.R., MERMELSTEIN, S.J., WAKSMAN, G., and DOWDY, S.F. (2001). Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-477.
36. HOLINGER, E.P., CHITTENDEN, T., and LUTZ, R.J. (1999). Bak BH3 peptides antagonize Bcl-XL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274, 13298-13304.
37. JO, D., NASHABI, A., DOXSEE, C., LIN, Q., UNUTMAZ, D., CHEN, J., and RULEY, H.E. (2001). Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nature Biotech. 19, 929-933.
38. KARDINAL, C., KONKOL, B., SCHULZ, A., POSERN, G., LIN, H., ADERMANN, K., EULITZ, M., ESTROV, Z., TALPAZ, M., ARLINGHAUS, R.B., and FELLER, S.M. (2000). Cell-penetrating SH3 domain blocker peptides inhibit proliferation of primary blast cells from CML patients. FASEB J. 14, 1529-1538.
39. INK4A fusion protein to human diploid fibroblasts. FEBS Lett. 427, 203-208.
40. KELEMEN, B.R., HSIAO, K., and GOUELI, S.A. (2002). Selective in vivo inhibition of mitogen-activated protein kinase activation using cell permeable peptides. J. Biol. Chem. 277, 8741-8748.
41. KELLER, P., PAYNE, J.L., TREMML, G., GREER, P.A., GABOLI, M., PANDOLFI, P.P., and BESSLER, M. (2001). FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J. Exp. Med. 194, 581-589.
42. LENEUVE, P., ZAOUI, R., MONGET, P., LE BOUC, Y., and HOLZENBERGER, M. (2001). Genotyping of Cre-lox mice and detection of tissue-specific recombination by multiplex PCR. Biotechniques 31, 1156-1160.
43. LEWIN, M., CARLESSO, N., TUNG, C.-H., TANG, X.-W., CORY, D., SCADDEN, D.T., and WEISSLEDER R. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotech. 18, 410-414.
44. KB by a synthetic peptide containing a cell membrane-permeable motif and a nuclear localization sequence. J. Biol. Chem. 270, 14255-14258.
45. LINDBERG, M., JARVET, J., LANGEL, U., and GRASLUND, A. (2001). Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochemistry 40, 3141-3149.
46. LINDGREN, M., GALLET, X., SOOMETS, U., HALLBRINK, M., BRAKENHIELM, E., POOGA, M., BRASSEUR, R., and LANGEL, U. (2000). Tranlocation properties of novel cell penetratng transportan and penetratin analogues. Bioconjugate Chem. 11, 619-626.
47. β3 using cell permeable peptide analogs. Proc. Natl. Acad. Sci. USA 93, 11819-11824.
48. MAGZOUB, M., KILK, K., ERIKSSON, L.E., LANGEL, U., and GRASLUND, A. (2001). Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles. Biochim. Biopbys. Acta 1512, 77-89.
49. MANN, D.A., and FRANKEL, A.D. (1991). Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739.
50. MI, Z., MAI, J., LU, Z., and ROBBINS, P.D. (2000). Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2, 339-347.
51. MORRIS, M.C., VIDAL, P., CHALOIN, L., HEITZ, F., and DIVITA, G. (1997). A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25, 2730-2736.
52. MORRIS, M.C., DEPOLLIER, J., MERY, J., HEITZ, F., and DIVITA, G. (2001). A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nature Biotech. 19, 1173-1176.
53. MURATOVSKA, A., LIGHTOWLERS, R.N., TAYLOR, R.W., WILCE, J.A., and MURPHY, M.P. (2001). Targeting large molecules to mitochondria. Adv. Drug Deliv. Rev. 49, 189-198.
54. NIELSEN, P.E. (1999). Peptide nucleic acids as therapeutic agents. Curr. Opin. Struct. Biol. 9, 353-357.
55. β-sheet forming peptide. FEBS Lett. 415, 196-199.
56. OEHLKE, J., SCHELLER, A., WIESNER, B., KRAUSE, E., BEYERMANN, M., KLAUSCHENZ, E., MELZIG, M., and BIENERT, M. (1998). Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-139.
57. PASQUALINI, R., KOIVUNEN, E., and RUOSLAHTI, E. (1997). Alpha v integrins as receptors for tumor targeting by circulating ligands. Nature Biotech. 15, 542-546.
58. PECK, D., and ISACKE, C.M. (1998). Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325. J. Cell Sci. 111, 1595- 1601.
59. PERSSON, D., THOREN, P.E.G., and NORDEN, B. (2001). Penetratin-induced aggregation and subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett. 505, 307-312.
60. PESCAROLO, M.P., BAGNASCO, L., MALACARNE, D., MELCHIORI, A., VALENTE, P., MILLO, E., BRUNO, S., BASSO, S., and PARODI S. (2001). A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems. FASEB J. 15, 31-33.
61. POOGA, M., SOOMETS, U., HALLBRINK, M., VALKNA, A., SAAR, K., REZAEI, K., KAHL, U., HAO, J.X., and XU, X.J. (1998). Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nature Biotech. 16, 857-861.
62. POOGA, M., KUT, C., KIHLMARK, M., HALLBRINK, M., FERNAEUS, S., RAID, R., LAND, T., HALLBERG, E., BARTFAI, T., and LANGEL, U. (2001a). Cellular translocation of proteins by transportan. FASEB J. 15, 1451-1453.
63. POOGA, M., LAND, T., BARTFAI, T., and LANGEL, U. (2001b). PNA oligomers as tools for specific modulation of gene expression. Biomol. Eng. 17, 183-192.
64. ROJAS, M., YAO, S., and LIN, Y.-Z. (1996). Controlling Epidermal Growth Factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J. Biol. Chem. 271, 27456-27461.
65. ROUSSELLE, C., CLAIR, P., LEFAUCONNIER, J.-M., KACZOREK, M., SCHERRMANN, J.-M., and TEMSAMANI, J. (2000). New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57, 679-686.
66. SAFFELL, J.L., WILLIAMS, E.J., MASON, I.J., WALSH, F.S., and DOHERTY, P. (1997). Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs. Neuron 18, 231-242.
67. SAHAI, E., OLSON, M.F., and MARSHALL, C.J. (2001). Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20, 755-766.
68. SAUZEAU, V., LE MELLIONNEC, E., BERTOGLIO, J., SCALBERT, E., PACAUD, P., and LOIRAND, G. (2001).Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 88, 1102-1104.
69. SCHELLER, A., OEHLKE, J., WIESNER, B., DATHE, M., KRAUSE, E., BEYERMANN, M., MELZIG, M., and BIERNERT, M. (1999). Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J. Peptide Sci. 5, 185-194.
70. SCHELLER, A., WIESNER, B., MELZIG, M., BIENERT, M., and OEHLKE, J. (2000). Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. Eur. J. Biochem. 267, 6043-6049.
71. SCHWARZE, S.R., HO, A., VOCERO-AKBANI, A., and DOWDY, S.F. (1999). In vivo protein transduction delivery of a biologically important protein into the mouse. Science 285, 1569-1572.
72. SCHWARZE, S.R., HRUSKA, K.A., and DOWDY, S.F. (2000). Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295.
73. SHELDON, K., LIU, D., FERGUSON, J., and GARIEPY, J. (1995). Loligomers: design of de novo peptide-based intracellular vehicles. Proc. Natl. Acad. Sci. USA 92, 2056-2060.
74. SHIMIZU, S., KONISHI, A., KODAMA, T., and TSUJIMOTO, Y. (2000). BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. USA 97, 3100-3105.
75. SOGA, N., NAMBA, N., MCALLISTER, S., CORNEIZUS, L., TEITELBAUM, S.L., DOWDY, S.F., KAWAMURA, J., and HRUSKA, K.A. (2001). Rho family GTPase regulate VEGF-stimulated endothelial cell motility. Exp. Cell Res. 269, 73-87.
76. SOHAL, D.S., NGHIEM, M., CRACKOWER, M.A., WITT, S.A., KIMBALL, T.R., TYMITZ, K.M., PENNINGER, (2001). Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89, 20-25.
77. SOOMETS, U., LINDGREN, M., GALLET, X., HALLBRINK, M., ELMQUIST, A., BALASPIRI, L., ZORKO, M., POOGA, M., BRASSEUR, R., and LANGEL, U. (2000). Deletion analogues of transportan. Biochim. Biophys. Acta 1467, 165-176.
78. THEODORE, L., DEROSSI, D., CHASSAING, G., LLIRBAT, B., KUBES, M., JORDAN, P., CHNEIWEISS, H., GODEMENT, P., and PROCHIANTZ, A. (1995). Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 15, 7158-7167.
79. THOREN, P.E.G., PERSSON, D., KARLSSON, M., and NORDEN, B. (2000). The Antennapedia protein translocates across lipid bilayers - the first direct observation. FEBS Lett. 482, 265-268.
80. TORCHILIN, V.P., RAMMOHAN, R., WEISSIG, V., and LEVCHENKO, T.S. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 98, 8786-8791.
81. TROY, C.M., DEROSSI, D., PROCHIANTZ, A., GREENE, L.A., and SHILANSKI, M.L. (1996a). Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16, 253-261.
82. β in apoptosis induced by trophic factor withdrawal and by copper/zince superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA 93, 5635-5640.
83. TURKSON, J., RYAN, D., KIM, J.S., ZHANG, Y., CHEN, Z., HAURA, E., LAUDANO, A., SEBTI, S., HAMILTON, A.D., and JOVE, R. (2001). Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation and cell transformation. J. Biol. Chem. 276, 45443-45555.
84. VILLA, R., FOLINI, M., LUALDI S., VERONESE, S., DAIDONE, M.G., and ZAFFARONI, N. (2000). Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in haman melanoma cells. FEBS Lett. 473, 241-248.
85. VIVES, E., BRODIN, P., and LEBLEU, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumalates in the cell nucleus. J. Biol. Chem. 272, 16010-16017.
86. VOCERO-AKBANI, A.M., VANDER HEYDEN, N., LISSY, N.A., RATNER, L., and DOWDY, S.F. (1999). Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nature Med. 5, 29-33.
87. WANG, J., DAI, H., YOUSAF, N., MOUSSAIF, M., DENG, Y., BOUFELLIGA, A., SWAMY, O.R., LEONE, M.E., and RIEDEL, H. (1999). Grb 10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I- and insulin-mediated mitogenesis. Mol. Cell. Biol. 19, 6217-6228.
88. WENDER, P.A., MITCHELL, D.J., PATTABIRAMAN, K., PELKEY, E.T., STEINMAN, L., and ROTHBARD, J.B. (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA 97, 13003-13008.
89. WILLIAMS, E.J., DUNICAN, D.J., GREEN, P.J., HOWELL, F.V., DEROSSI, D., WALSH, F.S., and DOHERTY, P. (1997). Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide. J. Biol. Chem. 272, 22349-22354.
90. ZELPHATI, O., WANG, Y., KITADA, S., REED, J.C., FELGNER, P.L., and CORBEIL, J. (2001). Intracellular delivery of proteins with a new lipid-mediated delivery system. J. Biol. Chem. 276, 35103-35110.
91. ZHOU, L., THIES, M., ALVAREZ-MAYA, I., BRENNER, M., WILLECKE, K., and MESSING, A. (2001). hGFAP-ere transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85-94.